Investments
210Portfolio Exits
51Funds
9Service Providers
1About New Leaf Venture Partners
New Leaf Venture Partners is a leader in healthcare technology venture investing. They focus primarily on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.
New Leaf Venture Partners Headquarter Location
7 Times Square Suite 3502
New York, New York, 10036,
United States
646-871-6400
Expert Collections containing New Leaf Venture Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find New Leaf Venture Partners in 3 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
113 items
Synthetic Biology
382 items
CB Insights Healthcare Smart Money Investors - 2020
25 items
Track the world's top-performing VC investors in healthcare. Firms are presented in alphabetical order.
Research containing New Leaf Venture Partners
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned New Leaf Venture Partners in 3 CB Insights research briefs, most recently on Feb 16, 2021.
Latest New Leaf Venture Partners News
Feb 16, 2022
Electra Therapeutics, a clinical stage biotechnology company developing antibody therapies that target signal regulatory proteins (SIRP), announced a $84 million Series B financing co-led by Westlake Village BioPartners and OrbiMed. Other participating investors include Redmile Group, Cormorant Asset Management, Cowen Healthcare Investments, RA Capital, and New Leaf Venture Partners. Electra was previously funded by its parent company, Star Therapeutics. Electra is building a pipeline of novel therapies targeting SIRP, a family of cell surface receptors on various immune cell types. The company is taking a first-in-class approach to engage SIRP beyond the current drug development efforts in cancer, by targeting specific SIRP proteins to deplete targeted pathological immune cells. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
New Leaf Venture Partners Investments
210 Investments
New Leaf Venture Partners has made 210 investments. Their latest investment was in Cleerly as part of their Series B - II on March 3, 2022.
New Leaf Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/14/2022 | Series B - II | Cleerly | $16.8M | No | 1 | |
2/16/2022 | Series B | Electra Therapeutics | $84M | Yes | 9 | |
2/16/2022 | Series A | Star Therapeutics | $100M | Yes | 2 | |
12/23/2021 | Series B - II | |||||
12/17/2021 | Series B - II |
Date | 3/14/2022 | 2/16/2022 | 2/16/2022 | 12/23/2021 | 12/17/2021 |
|---|---|---|---|---|---|
Round | Series B - II | Series B | Series A | Series B - II | Series B - II |
Company | Cleerly | Electra Therapeutics | Star Therapeutics | ||
Amount | $16.8M | $84M | $100M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 1 | 9 | 2 |
New Leaf Venture Partners Portfolio Exits
51 Portfolio Exits
New Leaf Venture Partners has 51 portfolio exits. Their latest portfolio exit was ReViral on April 07, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
4/7/2022 | Acquired | 9 | |||
1/26/2022 | Acq - Pending | 3 | |||
9/15/2021 | IPO | 3 | |||
Date | 4/7/2022 | 1/26/2022 | 9/15/2021 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acq - Pending | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 9 | 3 | 3 |
New Leaf Venture Partners Fund History
9 Fund Histories
New Leaf Venture Partners has 9 funds, including New Leaf Ventures III.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/31/2015 | New Leaf Ventures III | Multi-Stage Venture Capital | Closed | 2 | |
6/22/2015 | New Leaf Growth Fund I | ||||
10/23/2007 | New Leaf Ventures II | ||||
8/5/2005 | New Leaf Ventures I LP | ||||
12/31/2000 | Sprout Capital IX LP |
Closing Date | 12/31/2015 | 6/22/2015 | 10/23/2007 | 8/5/2005 | 12/31/2000 |
|---|---|---|---|---|---|
Fund | New Leaf Ventures III | New Leaf Growth Fund I | New Leaf Ventures II | New Leaf Ventures I LP | Sprout Capital IX LP |
Fund Type | Multi-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | |||||
Sources | 2 |
New Leaf Venture Partners Service Providers
1 Service Provider
New Leaf Venture Partners has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Counsel |
Service Provider | |
|---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type |
Partnership data by VentureSource
New Leaf Venture Partners Team
13 Team Members
New Leaf Venture Partners has 13 team members, including current Founder, Managing Director, Vijay Lathi.
Name | Work History | Title | Status |
|---|---|---|---|
Philippe Chambon | Founder | Current | |
Jeani Delagardelle | Delos Capital, Sprout Group, and Boston Scientific | Founder | Current |
Vijay Lathi | Founder, Managing Director | Current | |
Ian Wilson | Chief Executive Officer | Current | |
Craig Slutzkin | Chief Financial Officer | Current |
Name | Philippe Chambon | Jeani Delagardelle | Vijay Lathi | Ian Wilson | Craig Slutzkin |
|---|---|---|---|---|---|
Work History | Delos Capital, Sprout Group, and Boston Scientific | ||||
Title | Founder | Founder | Founder, Managing Director | Chief Executive Officer | Chief Financial Officer |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.